Expanded Access of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion for the Treatment of Pediatric Patients Who Have Failed to Respond to Steroid Treatment for Acute GVHD
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 14 Nov 2016
At a glance
- Drugs Remestemcel-L (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Sponsors Mesoblast
- 14 Nov 2016 Results published in a Mesoblast Limited media release.
- 25 Aug 2016 Data from this trial (n=241) presented at the tandem annual scientific meetings of the Center for International Blood & Marrow Transplant Research, the American Society of Blood and Marrow Transplantation and at the third International Conference on Regenerative Medicine.
- 16 Feb 2015 Interim results published in the Media Release.